𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The helix-loop-helix Id-1 inhibits PSA expression in prostate cancer cells

✍ Scribed by Anne J. Zielinski; Sylvia Fong; Juanita Allison; Misako Kawahara; Jean-Philippe Coppe; Heidi Feiler; Nancy M. Lee; Pierre-Yves Desprez


Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
202 KB
Volume
126
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The inhibitor of basic helix‐loop‐helix transcription factors, Id‐1, is an important gene whose expression increases during prostate cancer progression and that upregulates proliferation, migration and invasion. We used microarray analysis to identify the downstream genes whose transcriptional expression is modulated by Id‐1 protein. We compared gene expression in control LNCaP cells and Id‐1‐transduced LNCaP cells, which become significantly more aggressive after Id‐1 overexpression, thus mimicking the high levels of Id‐1 detected in metastatic cell lines. We used the Affy HTA U133A Expression Arrays with 45,000 probe sets representing more than 39,000 transcripts. We found that one of the most significantly downregulated genes on Id‐1 expression was kallikrein 3 [also called prostate specific antigen (PSA)], the most commonly used biomarker of prostate cancer. Here, we show that the reduction in PSA mRNA and protein expression associated with high‐grade prostate cancers, which generally express high levels of Id‐1, could be the consequence of Id‐1 overexpression.


📜 SIMILAR VOLUMES


Identification of DERMO-1 as a member of
✍ Masato Tamura; Masaki Noda 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

Several members of the basic helix-loop-helix (bHLH) type of transcription factors have now been reported, and almost every member of this class has been implicated in transcriptional regulation in cell type determination and differentiation. Previously, we reported that dominant negative HLH protei

Serenoa repens (Permixon®) inhibits the
✍ Fouad K. Habib; Margaret Ross; Clement K.H. Ho; Valerie Lyons; Karen Chapman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 109 KB

## Abstract The phytotherapeutic agent Serenoa repens is an effective dual inhibitor of 5α‐reductase isoenzyme activity in the prostate. Unlike other 5α‐reductase inhibitors, Serenoa repens induces its effects without interfering with the cellular capacity to secrete PSA. Here, we focussed on the p

Sulforaphane inhibited expression of hyp
✍ Hua Yao; Huiming Wang; Zhuo Zhang; Bing-Hua Jiang; Jia Luo; Xianglin Shi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 399 KB

## Abstract Previous studies show that a number of natural compounds from our diet have anticancer effects. Sulforaphane is the most characterized isothiocyanates (ITCs), which are identified in cruciferous vegetables. Sulforaphane is viewed as a conceptually promising agent in cancer prevention. B

EGF signalling in prostate cancer cell l
✍ Josien K. Oosterhoff; Liesbeth C. Kühne; J. Anton Grootegoed; Leen J. Blok 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 286 KB 👁 1 views

In advanced prostate cancer, cellular changes occur leading to a transition from androgen-dependent to androgen-independent growth. During this transition, proliferation of androgendependent prostate cancer cells becomes more and more dependent on growth factors, like the epidermal growth factor (EG

Switch to full-length of XAF1 mRNA expre
✍ Xiaolei Fang; Zhaoxu Liu; Yidong Fan; Chengyun Zheng; Sten Nilson; Lars Egevad; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 202 KB 👁 1 views

## Abstract X‐linked inhibitor of apoptosis protein (XIAP) suppresses apoptotic cell death by binding to caspases and inhibiting their functions, while the XIAP‐associated factor1 (XAF1), a zinc finger protein, antagonizes XIAP activities, thereby promoting apoptosis. The aberrant silence of the __